연구동향 분석

Original Article : Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection

( Ho Kil ) ( Sook Hyang Jeong ) ( Jin Wook Kim ) ( Young Sang Byoun ) ( Bo Young Min ) ( Byung Hyun Woo ) ( Jae Lee ) ( Young Seok Kim ) 2014년

논문상세정보
인용/피인용
' Original Article : Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 기초의학
  • hepatitis c
  • interleukin-28b
  • korea
  • recovery
  • treatment
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,809 0

0.0%

' Original Article : Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection' 의 참고문헌

  • Treatment of chronic hepatitis C in Asia: when East meets West
    Yu ML J Gastroenterol Hepatol 24 : 336 ~ 345 - [2009]
  • The global burden of hepatitis C
    Lavanchy D. Liver Int 29 (Suppl 1) : 74 ~ 81 - [2009]
  • The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
    Perz JF J Hepatol 45 : 529 ~ 538 - [2006]
  • Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
    Yu ML Hepatology 53 : 7 ~ 13 - [2011]
  • Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
    McCarthy JJ Gastroenterology 138 : 2307 ~ 2314 - [2010]
  • Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b
    Kawaoka T J Hepatol 54 : 408 ~ 414 - [2011]
  • Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
    Kurosaki M J Hepatol 54 : 439 ~ 448 - [2011]
  • Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
    Grebely J Hepatology 52 : 1216 ~ 1224 - [2010]
  • Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin
    Lyoo K J Clin Virol 52 : 363 ~ 366 - [2011]
  • Pegylated interferon-lambda (PEGIFN-λ) shows superior viral response with improved safety and tolerability versus PEGIFNα-2a in HCV patients (Gl/2/3/4): emerge phase IIB through week 12
    Zeuzem S J Hepatol 54 (Suppl 1) : S538 ~ S539 - [2011]
  • PEG-IFN-l: antiviral activity and safety profile in a 4-week phase 1b study in relapsed genotype 1 hepatitis C infection
    Shiffman M J Hepatol 50 (Suppl 1) : S237 ~ - [2009]
  • Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents
    Li Q Eur J Cancer 46 : 180 ~ 190 - [2010]
  • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
    Suppiah V Nat Genet 41 : 1100 ~ 1104 - [2009]
  • IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?
    Jensen DM Liver Int 32 (Suppl 1) : 74 ~ 78 - [2012]
  • IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC
    Fabris C J Hepatol 54 : 716 ~ 722 - [2011]
  • Hepatitis C virus infection
    Lauer GM N Engl J Med 345 : 41 ~ 52 - [2001]
  • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    Tanaka Y Nat Genet 41 : 1105 ~ 1109 - [2009]
  • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    Ge D Nature 461 ( ) : 399 ~ 401 - [2009]
  • Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
    Rauch A Gastroenterology 138 : 1338 ~ 1345 - [2010]
  • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
    Thomas DL Nature 461 : 798 ~ 801 - [2009]
  • EASL Clinical Practice Guidelines: management of hepatitis C virus infection
    European Association for the Study of the Liver J Hepatol 55 : 245 ~ 264 [2011]
  • Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian patients
    Sinn DH J Gastroenterol Hepatol 26 : 1374 ~ 1379 - [2011]
  • Antitumor activity of type I and type III interferons in BNL hepatoma model
    Abushahba W Cancer Immunol Immunother 59 : 1059 ~ 1071 - [2010]
  • American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update
    Bruix J Hepatology 53 : 1020 ~ 1022 - [2011]
  • American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
    Ghany MG Hepatology 54 : 1433 ~ 1444 - [2011]
  • Acute hepatitis C: current status and remaining challenges
    Santantonio T J Hepatol 49 : 625 ~ 633 - [2008]
  • Acute hepatitis C in Korea: different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion
    Kim JY J Med Virol 83 : 1195 ~ 1202 - [2011]
  • A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice
    Tillmann HL Gastroenterology 139 : 1586 ~ 1592 - [2010]